| Factor Information | |
|---|---|
| Data ID | 3535 |
| Factor | outcome measured by cardiovascular compromise |
| Description | Trend in outcome and patient condition by route of presentation by which congenital heart disease was recognised. |
| Biomarker | NA |
| Classification | A3 (clinical factor - disease & symptom) |
| Association | |
|---|---|
| Application | risk assessment and prognosis |
| Objective | To assess whether the route by which neonatal congenital heart disease (CHD) is first recognised influences outcome after surgery. |
| p Value | <0.01 |
| Conclusion | The setting in which neonatal CHD is first recognised has an impact on preoperative condition, which in turn influences postoperative progress and survival after surgery. Optimal screening procedures and access to specialist care will improve outcome for neonates undergoing cardiac surgery. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 682 |
| CHD Type | isolated CHD/non-isolated CHD |
| CHD Subtype | LHO/TGA/PA/SV/TAPVC/other |
| Reference | |
|---|---|
| PMID | 16449514 |
| Year | 2006 |
| Title | Delayed diagnosis of congenital heart disease worsens preoperative condition and outcome of surgery in neonates |
| Sample | ||
|---|---|---|
| Population | neonates | |
| Source | patients' data | |
| Region | London, United Kindom | |
| Method | χ2 test for trend | |
| Race | British | |
| Disease History | N/A | |
| Treatment History | N/A | |
| Group | N/A(Treatment) | N/A(Control) |
| Number | N/A | N/A |
| Age | N/A | N/A |
| Gender (Male: Female) | N/A | N/A |
| Marker Level | N/A | N/A |
